Discharge treatment with angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction-Reference-Cited by-同舟云学术

Discharge treatment with angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction

Published:2019-12 Issue:12 Volume:49 Page:1505-1513
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Vicent Lourdes¹^ORCID,Cinca Juan²,Vazquez‐García Rafael³,Gonzalez‐Juanatey José R.⁴,Rivera Miguel⁵,Segovia Javier⁶,Pascual‐Figal Domingo⁷,Bover Ramón⁸,Worner Fernando⁹,Delgado‐Jiménez Juan¹⁰,Fernández‐Avilés Francisco¹¹¹,Martínez‐Sellés Manuel¹¹¹¹²

Affiliation:

1. Cardiology DepartmentHospital General Universitario Gregorio Marañón, CIBERCV Madrid Spain

2. Cardiology DepartmentHospital de la Santa Creu i Sant Pau, CIBERCV Barcelona Spain

3. Cardiology DepartmentPuerta del Mar University Hospital Cádiz Spain

4. Cardiology DepartmentUniversity Hospital, CIBERCV Santiago de Compostela Spain

5. Cardiology DepartmentUniversity Hospital La Fe Spain

6. Cardiology DepartmentHospital Universitario Puerta de Hierro Majadahonda, CIBERCV Madrid Spain

7. Cardiology DepartmentHospital Clínico Universitario Virgen de la Arrixaca El Palmar Spain

8. Cardiology DepartmentHospital Clinico San Carlos Madrid Spain

9. Cardiology DepartmentHospital Universitari Arnau de Vilanova Lleida, IRBLLEIDA Spain

10. Cardiology DepartmentHospital Universitario 12 de Octubre Madrid Spain

11. Cardiology DepartmentUniversidad Complutense Madrid Spain

12. Universidad Europea Madrid Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.14289

Reference34 articles.

1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction

3. Mid‐range ejection fraction does not permit risk stratification among patients hospitalized for heart failure;Gómez‐Otero I;Rev Esp Cardiol,2017

4. Design of a bilevel clinical trial targeting adherence in heart failure patients and their providers: The Congestive Heart Failure Adherence Redesign Trial (CHART)

5. 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction;Journal of Clinical Medicine;2023-04-21

2. Individualizing the treatment of patients with heart failure with reduced ejection fraction: a journey from hospitalization to long-term outpatient care;Expert Opinion on Pharmacotherapy;2022-08-31

3. Heart Failure with Preserved Ejection Fraction in Children;Pediatric Cardiology;2022-08-17

4. Vericiguat en insuficiencia cardíaca: de la evidencia científica a la práctica clínica;Revista Clínica Española;2022-06

5. Vericiguat in heart failure: From scientific evidence to clinical practice;Revista Clínica Española (English Edition);2022-06